These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8043738)

  • 1. [Self-induced Cushing's syndrome due to dexamethasone abuse in nasal spray: clinical and biochemical study].
    Sastre J; Díez JJ; López Guzmán A; Iglesias P; Martínez I; Gómez-Pan A
    An Med Interna; 1994 Apr; 11(4):181-4. PubMed ID: 8043738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual profile of endocrine study in a patient with pre-Cushing's syndrome.
    Kodama C; Nakada T; Sasagawa I; Ishigooka M; Yamaguchi T; Suzuki H
    Int Urol Nephrol; 1993; 25(6):517-24. PubMed ID: 8175270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal function under long-term raloxifene administration.
    Genazzani AR; Lombardi I; Borgioli G; di Bono I; Casarosa E; Gambacciani M; Palumbo M; Genazzani AD; Luisi M
    Gynecol Endocrinol; 2003 Apr; 17(2):159-68. PubMed ID: 12737677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome.
    Sriussadaporn S; Ploybutr S; Peerapatdit T; Plengvidhya N; Nitiyanant W; Vannasaeng S; Vichayanrat A
    Br J Clin Pract; 1996; 50(1):9-13. PubMed ID: 8729595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and differential diagnosis of Cushing's syndrome].
    Penezić Z; Zarković M; Vujović S; Drezgić M
    Srp Arh Celok Lek; 2006; 134(11-12):558-66. PubMed ID: 17304774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
    Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
    Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cushing syndrome secondary to abuse of dexamethasone nasal spray.
    Champion PK
    Arch Intern Med; 1974 Oct; 134(4):750-1. PubMed ID: 4412687
    [No Abstract]   [Full Text] [Related]  

  • 11. [Current study of Cushing's syndrome, apropos of 3 cases].
    López Maciá A; Martin Santos FJ; Charro Salgado A; Cruz AF
    Rev Iber Endocrinol; 1976; 23(134):157-69. PubMed ID: 935731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iatrogenic Cushing's syndrome due to dexamethasone nasal drops.
    Kimmerle R; Rolla AR
    Am J Med; 1985 Oct; 79(4):535-7. PubMed ID: 4050838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cushing's syndrome induced by the use of dexamethasone administered nasally in spray form. Report of 3 cases].
    Halpern A; Hayahida CY; Pereira MA; Doi Sde Q; Lottenberg SA; Legrazie MC; Schnaider J; Carneiro CR; Bettarello A
    Rev Hosp Clin Fac Med Sao Paulo; 1981 Feb; 36(1):18-20. PubMed ID: 7280461
    [No Abstract]   [Full Text] [Related]  

  • 14. A 'smart' type of Cushing's syndrome.
    Razenberg AJ; Elte JW; Rietveld AP; van Zaanen HC; Cabezas MC
    Eur J Endocrinol; 2007 Dec; 157(6):779-81. PubMed ID: 18057386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cushing's syndrome and adrenal gland depression caused by intranasal spray containing dexamethasone in 2 siblings].
    Varotti C; Passarini B; Pasquali R
    G Ital Dermatol Venereol; 1987 Mar; 122(3):121-3. PubMed ID: 3596646
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cushing's syndrome and adrenal suppression by means of intranasal use of dexamethasone preparations].
    Reiner M; Galeazzi RL; Studer H
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1836-7. PubMed ID: 929148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cushing's syndrome due to abuse of dexamethasone nasal spray.
    Ortega LD; Grande RG
    Lancet; 1979 Jul; 2(8133):96. PubMed ID: 87988
    [No Abstract]   [Full Text] [Related]  

  • 18. Cushing's syndrome from the therapeutic use of intramuscular dexamethasone acetate.
    Hughes JM; Hichens M; Booze GW; Thorner MO
    Arch Intern Med; 1986 Sep; 146(9):1848-9. PubMed ID: 3753129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cushing's syndrome secondary to nasal instillation of dexamethasone].
    Domínguez Ortega L
    Rev Clin Esp; 1992 Jul; 191(3):169. PubMed ID: 1502409
    [No Abstract]   [Full Text] [Related]  

  • 20. Parotid fluid steroid responses to ACTH and dexamethasone in Cushing's syndrome.
    Shannon IL; Beering SC
    J Dent Assoc S Afr; 1970 Jan; 25(1):21-5. PubMed ID: 4312939
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.